Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Home spirometry improved monitoring of cystic fibrosis patients during COVID-19 pandemic

Publish date:: November 5, 2020

Key clinical point: Home spirometry could improve patient monitoring, even after the COVID-19 pandemic has passed.

Major finding: Home spirometry values averaged 2.01 mL lower than clinical spirometry values.

Study details: Post hoc retrospective analysis of a clinical trial (n = 267).

Disclosures: Mr. Paynter and Dr. Giusti have no relevant financial disclosures.

Citation:

Paynter A et al. NACFC 2020. Poster 643.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Pulmonology

E-cigarette use tied to increased COPD, asthma risk,

Obesity, hypoxia predict severity in children with COVID-19,

Telehealth finds acceptance among patients with CF, clinicians,

COVID-19 burdens follow patients after discharge,

Poverty raises depression risk in patients with cystic fibrosis,

All Specialties